Researches have developed new 'stepped care' approach to tackle uncontrolled high blood pressure.
Researchers at the Queen Mary University of London and Barts Health NHS Trust have successfully improved blood pressure control among patients with severe intolerance to antihypertensive medication by using medicines in unconventional ways and treating patients with a 'stepped care' approach.
The study devised a novel treatment strategy for 55 patients, involving fractional dosing with tablets, liquid formulations of antihypertensive drugs and patch formulations of antihypertensive drugs - plus use of unlicensed drugs that lower blood pressure.
After six months, blood pressure was significantly reduced among patients on the novel treatment strategy and the results were sustained.
The patients experienced no debilitating side effects.
Lead author Melvin Lobo of the Queen Mary University of London said this was an entirely new concept in tackling high blood pressure, adding that many of their patients had reported negative experiences with their doctors after complaining about drug side effects.
Lobo said that blood pressure control was vital as a means of avoiding serious cardiovascular events such as heart attack and stroke, adding that anti-hypertensive medication side effects are common and can be very debilitating.
She further said that patients will not have to suffer such side effects when there were alternative ways of treating them.
Lobo urged clinicians to be more sympathetic towards the patients, who report drug side effects.
The study is published in the Journal of Clinical Hypertension.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
